258 related articles for article (PubMed ID: 26745076)
1. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
[TBL] [Abstract][Full Text] [Related]
2. Plasma DNA integrity index as a potential molecular diagnostic marker for breast cancer.
Kamel AM; Teama S; Fawzy A; El Deftar M
Tumour Biol; 2016 Jun; 37(6):7565-72. PubMed ID: 26684805
[TBL] [Abstract][Full Text] [Related]
3. Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors.
Kohler C; Radpour R; Barekati Z; Asadollahi R; Bitzer J; Wight E; Bürki N; Diesch C; Holzgreve W; Zhong XY
Mol Cancer; 2009 Nov; 8():105. PubMed ID: 19922604
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood mammaglobin gene expression for diagnosis and prediction of metastasis in breast cancer patients.
Radwan WM; Moussa HS; Essa ES; Kandil SH; Kamel AM
Asia Pac J Clin Oncol; 2013 Mar; 9(1):66-70. PubMed ID: 22897908
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-based screening tool for breast cancer.
Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
[TBL] [Abstract][Full Text] [Related]
6. Circulating Cell Free Nuclear DNA, Mitochondrial DNA and Global DNA Methylation: Potential Noninvasive Biomarkers for Breast Cancer Diagnosis.
Pasha HA; Rezk NA; Riad MA
Cancer Invest; 2019; 37(9):432-439. PubMed ID: 31516038
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs in plasma as early detection markers for breast cancer.
Cuk K; Zucknick M; Heil J; Madhavan D; Schott S; Turchinovich A; Arlt D; Rath M; Sohn C; Benner A; Junkermann H; Schneeweiss A; Burwinkel B
Int J Cancer; 2013 Apr; 132(7):1602-12. PubMed ID: 22927033
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
[TBL] [Abstract][Full Text] [Related]
10. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
Yie SM; Luo B; Ye NY; Xie K; Ye SR
Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
[TBL] [Abstract][Full Text] [Related]
11. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
Silva J; García V; García JM; Peña C; Domínguez G; Díaz R; Lorenzo Y; Hurtado A; Sánchez A; Bonilla F
Breast Cancer Res; 2007; 9(4):R55. PubMed ID: 17711569
[TBL] [Abstract][Full Text] [Related]
12. Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes.
Schröder CP; Ruiters MHJ; de Jong S; Tiebosch ATMG; Wesseling J; Veenstra R; de Vries J; Hoekstra HJ; de Leij LFMH; de Vries EGE
Int J Cancer; 2003 Sep; 106(4):611-618. PubMed ID: 12845661
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA levels in blood and tissue samples from breast cancer patients of different stages.
Xia P; Wang HJ; Geng TT; Xun XJ; Zhou WJ; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(3):1339-44. PubMed ID: 24606462
[TBL] [Abstract][Full Text] [Related]
14. Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.
Wu X; Tanaka H
Oncotarget; 2015 Oct; 6(30):29795-807. PubMed ID: 26356673
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
[TBL] [Abstract][Full Text] [Related]
17. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
18. Serum tumour markers as a diagnostic and prognostic tool in Libyan breast cancer.
Elfagieh M; Abdalla F; Gliwan A; Boder J; Nichols W; Buhmeida A
Tumour Biol; 2012 Dec; 33(6):2371-7. PubMed ID: 22948780
[TBL] [Abstract][Full Text] [Related]
19. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
[TBL] [Abstract][Full Text] [Related]
20. Possible Prognostic Potential of RANKL and OPG in Metastatic Breast Cancer Egyptian Females.
Shaker OG; Elbaz EM
Asian Pac J Cancer Prev; 2020 Feb; 21(2):355-361. PubMed ID: 32102511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]